Prot #SD-809-C-18: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF SD-809 (DUTETRABENAZINE) FOR THE TREATMENT OF MODERATE TO SEVERE TARDIVE DYSKINESIA

Project: Research project

Project Details

StatusFinished
Effective start/end date10/24/14 → 10/24/17

Funding

  • INNO Clinical Outcomes, LLC (Prot #SD-809-C-18)
  • Auspex Pharmaceuticals, Inc. (Prot #SD-809-C-18)